0001062993-23-022719.txt : 20231218
0001062993-23-022719.hdr.sgml : 20231218
20231218130614
ACCESSION NUMBER: 0001062993-23-022719
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
EFFECTIVENESS DATE: 20231218
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Proteocyte Diagnostics Inc.
CENTRAL INDEX KEY: 0001987946
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-499990
FILM NUMBER: 231492931
BUSINESS ADDRESS:
STREET 1: MARS CENTRE, SOUTH TOWER
STREET 2: 101 COLLEGE STREET, SUITE 200
CITY: TORONTO
STATE: A6
ZIP: M5G 1L7
BUSINESS PHONE: (647) 255-1370
MAIL ADDRESS:
STREET 1: MARS CENTRE, SOUTH TOWER
STREET 2: 101 COLLEGE STREET, SUITE 200
CITY: TORONTO
STATE: A6
ZIP: M5G 1L7
D
1
primary_doc.xml
X0708
D
LIVE
0001987946
Proteocyte Diagnostics Inc.
MARS CENTRE, SOUTH TOWER
101 COLLEGE STREET, SUITE 200
TORONTO
A6
ONTARIO, CANADA
M5G 1L7
(647) 255-1370
ONTARIO, CANADA
None
None
Corporation
true
John
Jordan
MaRS Centre, South Tower
101 College Street, Suite 200
Toronto
A6
ONTARIO, CANADA
M5G 1L7
Executive Officer
Director
Steven
Arless
MaRS Centre, South Tower
101 College Street, Suite 200
Toronto
A6
ONTARIO, CANADA
M5G 1L7
Director
Mark
Hammer
MaRS Centre, South Tower
101 College Street, Suite 200
Toronto
A6
ONTARIO, CANADA
M5G 1L7
Executive Officer
Anthony
Morlandt
MaRS Centre, South Tower
101 College Street, Suite 200
Toronto
A6
ONTARIO, CANADA
M5G 1L7
Director
Barrie
Renick
MaRS Centre, South Tower
101 College Street, Suite 200
Toronto
A6
ONTARIO, CANADA
M5G 1L7
Director
Carlo
Sistilli
MaRS Centre, South Tower
101 College Street, Suite 200
Toronto
A6
ONTARIO, CANADA
M5G 1L7
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-12-04
false
true
true
true
Convertible Note (the ?Note?) in the principal amount of C$50,000. The type and class of share that the Note converts into will be determined at a future date (upon a future "qualified financing"). The note carries an interest rate of 8% per annum.
false
50000
36925
36925
0
Total Offering Amount represents the principal amount of the Note. Based on Bank of Canada exchange rate reported on December 4, 2023 CAD$1.00:USD$0.7385.
false
1
0
0
0
false
Proteocyte Diagnostics Inc.
/s/ John Jordan
John Jordan
Chief Financial Officer
2023-12-18